Abstract
Axin, a negative regulator of Wnt signaling, is a key scaffold protein for the β-catenin destruction complex. It has been previously shown that multiple post-translational modification enzymes regulate the level of Axin. Here, we provide evidence that protein arginine methyltransferase 1 (PRMT1) directly interacts with and methylates the 378th arginine residue of Axin both in vitro and in vivo. We found that the transient expression of PRMT1 led to an increased level of Axin and that knockdown of endogenous PRMT1 by short hairpin RNA reduced the level of Axin. These results suggest that methylation by PRMT1 enhanced the stability of Axin. Methylation of Axin by PRMT1 also seemingly enhanced the interaction between Axin and glycogen synthase kinase 3β, leading to decreased ubiquitination of Axin. Consistent with the role of PRMT1 in the regulation of Axin, knockdown of PRMT1 enhanced the level of cytoplasmic β-catenin as well as β-catenin-dependent transcription activity. In summary, we show that the methylation of Axin occurred in vivo and controlled the stability of Axin. Therefore, methylation of Axin by PRMT1 may serve as a finely tuned regulation mechanism for Wnt/β-catenin signaling.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Bedford MT . (2007). Arginine methylation at a glance. J Cell Sci 120: 4243–4246.
Bedford MT, Clarke SG . (2009). Protein arginine methylation in mammals: who, what, and why. Mol Cell 33: 1–13.
Bedford MT, Frankel A, Yaffe MB, Clarke S, Leder P, Richard S . (2000). Arginine methylation inhibits the binding of proline-rich ligands to Src homology 3, but not WW, domains. J Biol Chem 275: 16030–16036.
Bedford MT, Richard S . (2005). Arginine methylation an emerging regulator of protein function. Mol Cell 18: 263–272.
Bienz M, Clevers H . (2000). Linking colorectal cancer to Wnt signaling. Cell 103: 311–320.
Boisvert FM, Chenard CA, Richard S . (2005). Protein interfaces in signaling regulated by arginine methylation. Sci STKE 2005: re2.
Cadigan KM, Nusse R . (1997). Wnt signaling: a common theme in animal development. Genes Dev 11: 3286–3305.
Cong F, Schweizer L, Varmus H . (2004). Wnt signals across the plasma membrane to activate the beta-catenin pathway by forming oligomers containing its receptors, Frizzled and LRP. Development 131: 5103–5115.
Dajani R, Fraser E, Roe SM, Yeo M, Good VM, Thompson V et al. (2003). Structural basis for recruitment of glycogen synthase kinase 3beta to the axin-APC scaffold complex. EMBO J 22: 494–501.
Davidson G, Wu W, Shen J, Bilic J, Fenger U, Stannek P et al. (2005). Casein kinase 1 gamma couples Wnt receptor activation to cytoplasmic signal transduction. Nature 438: 867–872.
Fagotto F, Jho E, Zeng L, Kurth T, Joos T, Kaufmann C et al. (1999). Domains of axin involved in protein-protein interactions, Wnt pathway inhibition, and intracellular localization. J Cell Biol 145: 741–756.
Goulet I, Gauvin G, Boisvenue S, Cote J . (2007). Alternative splicing yields protein arginine methyltransferase 1 isoforms with distinct activity, substrate specificity, and subcellular localization. J Biol Chem 282: 33009–33021.
Gupta P, Ho PC, Huq MD, Khan AA, Tsai NP, Wei LN . (2008). PKCepsilon stimulated arginine methylation of RIP140 for its nuclear-cytoplasmic export in adipocyte differentiation. PLoS One 3: e2658.
Huang SM, Mishina YM, Liu S, Cheung A, Stegmeier F, Michaud GA et al. (2009). Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling. Nature 461: 614–620.
Jernigan KK, Cselenyi CS, Thorne CA, Hanson AJ, Tahinci E, Hajicek N et al. (2010). Gbetagamma activates GSK3 to promote LRP6-mediated beta-catenin transcriptional activity. Sci Signal 3: ra37.
Jho E, Lomvardas S, Costantini F . (1999). A GSK3beta phosphorylation site in axin modulates interaction with beta-catenin and Tcf-mediated gene expression. Biochem Biophys Res Commun 266: 28–35.
Jung H, Kim HJ, Lee SK, Kim R, Kopachik W, Han JK et al. (2009). Negative feedback regulation of Wnt signaling by Gbetagamma-mediated reduction of Dishevelled. Exp Mol Med 41: 695–706.
Kim MJ, Chia IV, Costantini F . (2008). SUMOylation target sites at the C terminus protect Axin from ubiquitination and confer protein stability. FASEB J 22: 3785–3794.
Kim S, Jho EH . (2010). The protein stability of Axin, a negative regulator of Wnt signaling, is regulated by Smad ubiquitination regulatory factor 2 (Smurf2). J Biol Chem 285: 36420–36426.
Kimelman D, Xu W . (2006). beta-Catenin destruction complex: insights and questions from a structural perspective. Oncogene 25: 7482–7491.
Latres E, Chiaur DS, Pagano M . (1999). The human F box protein beta-Trcp associates with the Cul1/Skp1 complex and regulates the stability of beta-catenin. Oncogene 18: 849–854.
Lee E, Salic A, Kruger R, Heinrich R, Kirschner MW . (2003). The roles of APC and Axin derived from experimental and theoretical analysis of the Wnt pathway. PLoS Biol 1: E10.
Liu C, Li Y, Semenov M, Han C, Baeg GH, Tan Y et al. (2002). Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism. Cell 108: 837–847.
Logan CY, Nusse R . (2004). The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 20: 781–810.
Luo W, Lin SC . (2004). Axin: a master scaffold for multiple signaling pathways. Neurosignals 13: 99–113.
Luo W, Peterson A, Garcia BA, Coombs G, Kofahl B, Heinrich R et al. (2007). Protein phosphatase 1 regulates assembly and function of the beta-catenin degradation complex. EMBO J 26: 1511–1521.
Lyu J, Yamamoto V, Lu W . (2008). Cleavage of the Wnt receptor Ryk regulates neuronal differentiation during cortical neurogenesis. Dev Cell 15: 773–780.
MacDonald BT, Tamai K, He X . (2009). Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell 17: 9–26.
McBride AE, Weiss VH, Kim HK, Hogle JM, Silver PA . (2000). Analysis of the yeast arginine methyltransferase Hmt1p/Rmt1p and its in vivo function. Cofactor binding and substrate interactions. J Biol Chem 275: 3128–3136.
McBride AE, Silver PA . (2001). State of the arg: protein methylation at arginine comes of age. Cell 106: 5–8.
Moon RT, Brown JD, Torres M . (1997). WNTs modulate cell fate and behavior during vertebrate development. Trends Genet 13: 157–162.
Mowen KA, Tang J, Zhu W, Schurter BT, Shuai K, Herschman HR et al. (2001). Arginine methylation of STAT1 modulates IFNalpha/beta-induced transcription. Cell 104: 731–741.
Nicholson TB, Chen T, Richard S . (2009). The physiological and pathophysiological role of PRMT1-mediated protein arginine methylation. Pharmacol Res 60: 466–474.
Pawlak MR, Scherer CA, Chen J, Roshon MJ, Ruley HE . (2000). Arginine N-methyltransferase 1 is required for early postimplantation mouse development, but cells deficient in the enzyme are viable. Mol Cell Biol 20: 4859–4869.
Polakis P . (2000). Wnt signaling and cancer. Genes Dev 14: 1837–1851.
Rui HL, Fan E, Zhou HM, Xu Z, Zhang Y, Lin SC . (2002). SUMO-1 modification of the C-terminal KVEKVD of Axin is required for JNK activation but has no effect on Wnt signaling. J Biol Chem 277: 42981–42986.
Salahshor S, Woodgett JR . (2005). The links between axin and carcinogenesis. J Clin Pathol 58: 225–236.
Salic A, Lee E, Mayer L, Kirschner MW . (2000). Control of beta-catenin stability: reconstitution of the cytoplasmic steps of the wnt pathway in Xenopus egg extracts. Mol Cell 5: 523–532.
Satoh S, Daigo Y, Furukawa Y, Kato T, Miwa N, Nishiwaki T et al. (2000). AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1. Nat Genet 24: 245–250.
Shimizu Y, Ikeda S, Fujimori M, Kodama S, Nakahara M, Okajima M et al. (2002). Frequent alterations in the Wnt signaling pathway in colorectal cancer with microsatellite instability. Genes Chromosomes Cancer 33: 73–81.
Tang J, Frankel A, Cook RJ, Kim S, Paik WK, Williams KR et al. (2000). PRMT1 is the predominant type I protein arginine methyltransferase in mammalian cells. J Biol Chem 275: 7723–7730.
Teyssier C, Ma H, Emter R, Kralli A, Stallcup MR . (2005). Activation of nuclear receptor coactivator PGC-1alpha by arginine methylation. Genes Dev 19: 1466–1473.
Tolwinski NS, Wieschaus E . (2004). Rethinking WNT signaling. Trends Genet 20: 177–181.
Willert K, Jones KA . (2006). Wnt signaling: is the party in the nucleus? Genes Dev 20: 1394–1404.
Willert K, Shibamoto S, Nusse R . (1999). Wnt-induced dephosphorylation of axin releases beta-catenin from the axin complex. Genes Dev 13: 1768–1773.
Winston JT, Strack P, Beer-Romero P, Chu CY, Elledge SJ, Harper JW . (1999). The SCFbeta-TRCP-ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in IkappaBalpha and beta-catenin and stimulates IkappaBalpha ubiquitination in vitro. Genes Dev 13: 270–283.
Yamamoto H, Kishida S, Kishida M, Ikeda S, Takada S, Kikuchi A . (1999). Phosphorylation of axin, a Wnt signal negative regulator, by glycogen synthase kinase-3beta regulates its stability. J Biol Chem 274: 10681–10684.
Yu Z, Chen T, Hebert J, Li E, Richard S . (2009). A mouse PRMT1 null allele defines an essential role for arginine methylation in genome maintenance and cell proliferation. Mol Cell Biol 29: 2982–2996.
Zeng X, Huang H, Tamai K, Zhang X, Harada Y, Yokota C et al. (2008). Initiation of Wnt signaling: control of Wnt coreceptor Lrp6 phosphorylation/activation via frizzled, dishevelled and axin functions. Development 135: 367–375.
Zeng X, Tamai K, Doble B, Li S, Huang H, Habas R et al. (2005). A dual-kinase mechanism for Wnt co-receptor phosphorylation and activation. Nature 438: 873–877.
Zhao X, Jankovic V, Gural A, Huang G, Pardanani A, Menendez S et al. (2008). Methylation of RUNX1 by PRMT1 abrogates SIN3A binding and potentiates its transcriptional activity. Genes Dev 22: 640–653.
Acknowledgements
This work was supported by grants from the Korea Research Foundation (C00339) and the National R&D Program for Cancer Control, Ministry for Health and Welfare, Republic of Korea (1020240) to E Jho B Cha, W Kim and B Hwang were supported by the Brain Korea 21 program. B Cha and W Kim were recipients of the Seoul Science Fellowship.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
Our work is original research, has not been previously published and has not been submitted for publication elsewhere while under consideration. We declare that there is no competing financial interest in relation to our work described in the manuscript.
Additional information
Supplementary Information accompanies the paper on the Oncogene website
Rights and permissions
About this article
Cite this article
Cha, B., Kim, W., Kim, Y. et al. Methylation by protein arginine methyltransferase 1 increases stability of Axin, a negative regulator of Wnt signaling. Oncogene 30, 2379–2389 (2011). https://doi.org/10.1038/onc.2010.610
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/onc.2010.610
Keywords
This article is cited by
-
The scaffold protein AXIN1: gene ontology, signal network, and physiological function
Cell Communication and Signaling (2024)
-
PRMT7 ablation in cardiomyocytes causes cardiac hypertrophy and fibrosis through β-catenin dysregulation
Cellular and Molecular Life Sciences (2022)
-
Methylation of EZH2 by PRMT1 regulates its stability and promotes breast cancer metastasis
Cell Death & Differentiation (2020)
-
PRMT1 promotes pancreatic cancer growth and predicts poor prognosis
Cellular Oncology (2020)
-
The arginine methyltransferase PRMT5 and PRMT1 distinctly regulate the degradation of anti-apoptotic protein CFLARL in human lung cancer cells
Journal of Experimental & Clinical Cancer Research (2019)